Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Accuray (radiosurgery system for cancer) netted $174mm through its initial public offering of 10.4mm common shares (including the overallotment) at $18 each. The company had originally planned to offer 7.33mm shares priced between $14-16. Selling stockholders also issued 8mm shares.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?